Hypervision Surgical Secures £17 Million to Enhance Operating Room Precision with AI

Hypervision Surgical Secures £17 Million to Enhance Operating Room Precision with AI

2026-04-29 companies

London, Wednesday, 29 April 2026.
A £17 million funding round will equip operating rooms with AI-powered imaging, allowing surgeons to see previously invisible tissue details in real time to improve patient safety.

Beyond the Human Eye: The Technology Driving Precision

Hypervision Surgical, a spin-out from King’s College London, aims to use the newly secured funds to transform hyperspectral sensing into a scalable, cloud-enabled platform for artificial intelligence-assisted surgery [1][2]. Co-developed with the nanoelectronics research and development hub imec, this technology captures spectral information that goes far beyond the capabilities of conventional cameras and the human eye [1][2]. By combining advanced spectral sensing with AI analytics, the platform provides real-time, pixel-level quantitative insights into tissue physiology, which were previously invisible to surgeons [1][3].

Strategic Clinical Partnerships and Patient Safety

A primary focus of the Series A funding is improving patient safety by reducing intraoperative complications [1]. The participation of Macmillan Cancer Support underscores the real-world clinical urgency of the technology [4]. According to the charity, real-time quantitative vision can help surgeons achieve greater precision during cancer operations, potentially preventing devastating, life-altering side effects such as the need for permanent stoma bags [4]. Suzuka Jomori led the investment on behalf of Macmillan Ventures [4].

Scaling the Future of AI-Assisted Surgery

Moving forward, Hypervision Surgical plans to integrate its Hyperspectral Intelligence platform across a wide array of surgical environments, including laparoscopic, robotic, microscopic, and endoscopic systems [1]. This broad integration is designed to harness data from the hundreds of millions of surgeries performed globally each year [1]. Michael Ebner, CEO and Co-Founder of Hypervision Surgical, noted that combining spectral sensing with cloud-enabled AI analytics effectively builds a “new intelligence layer in surgery,” granting surgeons access to critical tissue data in real time [1].

Sources


Venture Capital HealthTech